FDA DISCLAIMER The statements made regarding these products have not been evaluated by the Food and Drug Administration
Three markers to track weekly: Weight stability or minimal gain (under 1% of bodyweight per week is acceptable
At Set Point Medical Weight Loss Clinic, our team provides individualized guidance on nutrition, exercise, and behavioral strategies to complement tirzepatide therapy
These studies consistently report favourable renal outcomes (e.g., eGFR, macroalbuminuria, or serum creatinine levels) with GLP-1 receptor agonists
Make it a part of your daily routine to experience its potential fat loss benefits over time
This is especially important for those using compounded semaglutide or branded options like Wegovy, as the rapid weight loss can outpace your bodys ability to maintain muscle